Sorrento Therapeutics Inc (SRNE): I expect SEMDEXA, Abivertinib, COVI-AMG,...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Tuesday, 12/21/2021 5:03:04 PM

Tuesday, December 21, 2021 5:03:04 PM

I expect SEMDEXA, Abivertinib, COVI-AMG, COVIDROPS and COVI-MSC all will be approved in Mexico, Brazil, Europe and even the US in 2022.
That is why I expect a triple digit Sorrento share price in 2022.
When in 2022? The sooner the approvals, the sooner the revenue, the sooner the dramatic increase in Sorrento share price.
As a retail investor I don't know what is going on inside the company...but I like my chances. There will be partnerships. They may even be followed by a buyout...but not for less than triple digits IMO!

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM